Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of this observational study is to evaluate the
incidence of serious adverse drug reactions while using Levemir® under normal clinical
practice conditions.